Eisai
4523.T
#2079
Rank
C$13.18 B
Marketcap
C$46.73
Share price
6.09%
Change (1 day)
12.72%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2026 (TTM): C$0.52 Billion

According to Eisai's latest financial reports the company's current earnings are C$5.44 Billion. In 2025 the company made an earning of C$0.59 Billion a decrease over its 2024 earnings that were of C$0.75 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.52 B-12.95%
2025 C$0.59 B-20.48%
2024 C$0.75 B2.42%
2023 C$0.73 B-2404.04%
2022 -C$31.84 Million-103.6%
2021 C$0.88 B-39.81%
2020 C$1.47 B7.44%
2019 C$1.36 B17.22%
2018 C$1.16 B86.16%
2017 C$0.62 B-23.52%
2016 C$0.82 B26.97%
2015 C$0.64 B22.3%
2014 C$0.52 B-46.07%
2013 C$0.97 B-21.85%
2012 C$1.25 B-20.59%
2011 C$1.57 B-8.91%
2010 C$1.73 B19.21%
2009 C$1.45 B